Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Hims & Hers Health, Inc.(HIMS) | 273,151 | 273,151 | 0 | 8,072 | 13,617 | 16.87% | +5,545 |
| CG Oncology, Inc.(CGON) | 859,050 | 1,004,050 | +145,000 | 21,038 | 26,105 | 32.34% | +5,067 |
| Lyell Immunopharma Inc(LYEL) | 0 | 406,652 | +406,652 | 0 | 3,595 | 4.45% | +3,595 |
| Disc Medicine, Inc.(IRON) | 299,069 | 299,069 | 0 | 14,846 | 15,839 | 19.62% | +993 |
| Maze Therapeutics Inc(MAZE) | 345,191 | 345,191 | 0 | 3,801 | 4,235 | 5.25% | +435 |
| Lyell Immunopharma Inc(LYEL) | 8,133,047 | 0 | -8,133,047 | 4,376 | 0 | — | -4,376 |
| Alumis Inc | 5,779,348 | 5,779,348 | 0 | 35,485 | 17,338 | 21.48% | -18,147 |